Dual diagnosis: Discovery of a critical role for environmental exposure

Journal of Dual Diagnosis

Volumn 1, Issue 1, 2004, Pages 5-13

  Gold, Mark S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Addiction; Co mordibity; Dependence; Dual disorders; Environmental exposure; Fentanyl; Opiate; Second hand smoke; Toxic workplace

Indexed keywords

BRAIN MONOAMINE; FENTANYL; OPIATE;

ANHEDONIA; COMORBIDITY; DEPRESSION; DRUG ABUSE; DRUG DEPENDENCE; DRUG INTOXICATION; DYSPHORIA; ENVIRONMENTAL EXPOSURE; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MESOLIMBIC DOPAMINERGIC SYSTEM; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; OPIATE ADDICTION; PASSIVE SMOKING; PSYCHIATRIC DIAGNOSIS; REVIEW; UNITED STATES; WITHDRAWAL SYNDROME;

EID: 24144472284     PISSN: 15504263     EISSN: None     Source Type: Journal    
DOI: 10.1300/J374v01n01_02     Document Type: Review

References (36)

1. Extein I, Gold MS, (eds), Medical Mimics of Psychiatric Disorders, American Psychiatric Association Press, Washington, DC, 1-302, 1986.
2. Gold MS, Slaby AE, (eds.), Dual Diagnosis in Substance Abuse. Marcel Dekker, Inc., New York 1991; 1-341.
3. Dackis CA, Gold MS: Depression in Opiate Addicts. In Mirin SM, (ed), Substance Abuse and Psychopathology. Washington, American Psychiatric Press, Inc. 1984; 20-39.
4. Kleber HD, Gold MS. Use of psychotropic drugs in treatment of methadone maintained narcotic addicts. Ann NY Acad Sci 1978;311:81-98.
5. Estroff TW, Gold MS: Medication Induced and Toxin Induced Psychiatric Disorder. Chapter 7. In Extein I, Gold MS, (eds), Medical Mimics of Psychiatric Disorders, American Psychiatric Association Press, Washington, DC, 1986; 163-198.
6. Dackis CA, Gold MS: Psychopathology resulting from substance abuse. In Gold MS, Slaby AE (eds): Dual Diagnosis in Substance Abuse, Marcel Dekker, Inc., New York, 1991; 205-220.
7. Gold MS, Aronson MD. Treatment of Alcoholism, Harvard University's UpToDate, www and CD ROM Educational Program, 2004.
8. Miller NS, Gold MS: Suggestions for changes in criteria for substance use disorders in DSM III R. Am J Drug Alcohol Abuse. 1989;15(2):223-230.
9. Gold MS, Byars JA, Frost-Pineda K, Pusey AE. Substance Use In Women, in Special Issues in Women's Healthcare Submitted to ACOG, 2004.
10. Jacobs W, DuPont R, Gold MS. Drug Testing and The DSM V. Psych Ann. 2000; 30:9 583-588.
11. Robins, L.N. & Regier, D.A. Psychiatric Disorders in America: The Epidemiological Catchment Area Study 1991. New York: Free Press.
12. Reiger, DA, Myers, JK, Kramer, M, Robins, LN, Blazer, DG, Hough, RI, Eaton, WW., Locked, BZ. 1984. The NIMH epidemiologic catchment area program. Archives of General Psychiatry 41:934-941.
13. Kessler, R., Nelson, C., McGonagle, K. The Epidemiology of Co-occurring Addictive and Mental Disorders: Implications for Prevention and Service Utilization. American Journal of Orthopsychiatry 1996;66:17-31.
14. Abram, KM, Teplin, LA, McClelland, GM, Dulcan, MK. Comorbid psychiatric disorders in youth in juvenile detention. Arch Gen Psychiat 60:1097-1108, 2003.
15. Lewis, DC. The role of the generalist in the care of the substance-abusing patient. Medical Clinics of North America. 81:4:831-843, 1997.
16. Dackis CA, Gold MS: New Concepts in Cocaine Addiction: The Dopamine Depletion Hypothesis. Neuro and Biobehav Rev 1985;9(3):469-477.
17. Miller NS, Klamen D, Hoffmann NG, Flaherty JA. Prevalence of depression and alcohol and other drug dependence in addictions treatment populations. J Psychoactive Drugs 1996;28:111-124.
18. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
19. Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am J Psychiatry 1997;154:948-957.
20. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL et al. Comorbidity of mental disorders with alcohol and other drag abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-2518.
21. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 1996;66:17-31.
22. Roy A, DeJong J, Lamparski D, George T, Linnoila M. Depression among alcoholics. Relationship to clinical and cerebrospinal fluid variables. Arch Gen Psychiatry 1991;48:428-432.
23. Schuckit MA. The clinical implications of primary diagnostic groups among alcoholics. Arch Gen Psychiatry 1985;42:1043-1049.
24. Kleber HD, Gold MS: Use of psychotropic drugs in treatment of methadone maintained narcotic addicts. Ann NY Acad Sci. 1978;311:81-98.
25. Dackis, CA, Gold MS, Sweeney DR: The Physiology of Cocaine Craving and "Crashing." Arch Gen Psychiatry 1987;44(3):298-299.
26. Gold MS, Dackis CA: New Insights and Treatments: Narcotics and Cocaine Addiction. Clinical Therapeutics 1985;7(1):6-21.
27. Weiss F, Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP et al. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann N Y Acad Sci 2001;937:1-26.
28. Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci 1999;22:521-527.
29. Rossetti ZL, Hmaidan Y, Gessa GL. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 1992;221:227-234.
30. Washton AM, Pottash ALC, Gold MS: Naltrexone in Addicted Business Executives and Physicians. J Clin Psychiatry. 1984;45(9):39-41.
31. Gold MS, Pomm R, Kennedy Y, Jacobs W, Frost-Pineda K. 5-Year State-Wide Study pf Physician Addiction Treatment Outcomes Confirmed By Urine Testing Society For Neuroscience, San Diego, CA, November 13, 2001.
32. Verghese A. Physicians and addiction. N Engl J Med 2002; 6;346(20):1510-1.
33. Gold MS, Extein I, Perzel J, Annitto WJ. Naltrexone in the treatment of physician addicts. American Psychiatric Association Abstract 1982;95:275.
34. Gold MS, Melker RJ, Dennis DM, Morey TE, Bajpai LK, Gravenstein N, Pomm R, Frost-Pineda K. Exposure to Opioids In The Operating Room: An Occupational Hazard for Anesthesiologists. Psychosomatics (submitted 2004).
35. Gold MS, Melker RJ, Dennis DM, Morey TE, Bajpai LK, Gravenstein N, Frost-Pineda K, Kennedy Y and Pomm R. Addiction as an Occupational Hazard for Anesthesiologists: Access or Secondhand Exposure? JAMA Letters (submitted Feb. 2004).
36. Gold MS, Pomm R, Kennedy Y, Jacobs W, Frost-Pineda K. Five-year state-wide study of physician addiction treatment outcomes confirmed by urine testing. Program No. 668.1.2001 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2001. Online at www.sfn.org.